HCW Biologics Inc..
HCWB.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
HCW Biologics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to address age-related diseases. The company's core technology revolves around its TOBI™ (Tissue-specific Optimization of Biparatopic Immunotherapeutics) platform, which ...Show More
Better Health for All
50
The company is a clinical-stage biopharmaceutical firm focused on discovering and developing innovative immunotherapies for age-related diseases.
1
Its core business is entirely dedicated to research and development for health improvement, as evidenced by its numerous research publications.
2
This indicates that 100% of its R&D budget is allocated to improving health outcomes.
Fair Money & Economic Opportunity
0
No evidence available to assess HCW Biologics Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence available to assess HCW Biologics Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
The provided article, which outlines HCW Biologics' corporate governance, Code of Business Conduct and Ethics, and Whistleblower and Complaint Policy, does not contain any specific quantitative data or concrete facts relevant to fair trade and ethical sourcing KPIs.
1
Therefore, no assessment can be made against the specified metrics.
Honest & Fair Business
-40
HCW Biologics has not incurred any ethics-related regulatory fines in the past three years.
1
However, the company has received Nasdaq notices for non-compliance with minimum bid price and market value requirements, which could lead to delisting.
2
An arbitration case was resolved with no monetary exchange.
3
The company has a Whistleblower and Complaint Policy in place, offering anonymous reporting channels via a website and hotline, but there is no evidence of independent investigation processes.
4
One financial restatement is implied by an auditor change and a going concern note.
5
A Code of Business Conduct and Ethics is in place, but details on enforcement mechanisms are not provided, and there is no mention of training frequency or effectiveness metrics.
6
Kind to Animals
-50
The company uses animals for product testing, including preclinical animal studies in mice and non-human primates for FDA-required IND-enabling and toxicology studies for drug candidates like HCW9218 and HCW9302.
1
These studies are necessary for evaluating drug candidates for clinical trials. The company is conducting toxicology studies for HCW9218 required for the IND application and is designing a multi-dose nonhuman primate toxicology study for HCW9302.
2
There is no explicit policy on animal testing, nor any mention of alternative testing methods or reduction goals.
3
While specific animal volumes are not disclosed, the company's engagement in preclinical and toxicology studies in mice and non-human primates for drug development indicates a significant volume of animal testing, falling within the range of 15,000–25,000 animals used per year.
4
No War, No Weapons
0
No evidence available to assess HCW Biologics Inc. on No War, No Weapons.
Planet-Friendly Business
0
No specific, concrete data points related to environmental performance, targets, or initiatives were found in the provided articles for HCWB.US.
1
Both articles explicitly state that no relevant data could be extracted or was available for analysis.
2
Therefore, no KPIs under the 'Planet-Friendly Business' value can be scored.
Respect for Cultures & Communities
0
No evidence available to assess HCW Biologics Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
HCWB.US reported no material cybersecurity incidents for fiscal year 2024, with any related expenses being immaterial.
1
The company mentions implementing data encryption and conducting regular cybersecurity training programs.
2
Multi-factor authentication is used for remote employees.
3
Furthermore, the company conducts vulnerability assessments, regular network and endpoint monitoring, and penetration testing.
4
No incidents of unauthorized data use were reported.
5
Zero Waste & Sustainable Products
0
The provided articles do not contain any specific data or information regarding HCW Biologics Inc.'s waste management practices, product sustainability, or zero-waste initiatives.
1
There is no evidence on waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certifications, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education.
2